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In this case, one of the main pathologies that will be 
introduced is pulmonary thromboembolism (PTE). This 
is a life-threatening syndrome produced by vascular ob-
struction in the pulmonary vasculature. Frequently, it is a 
consequence of deep venous thrombosis (DVT). As a mat-
ter of fact, the thrombus formation factors are the same in 
both cases, namely hypercoagulability, endothelial injury 
and alterations in blood flow (1). Its non-specific clinical 
presentation may vary between dyspnea, cough, pleuritic 
or substernal chest pain and tachypnea, tachycardia, hy-
potension, fever or cyanosis; depending essentially on the 
embolus size and the previous cardio-respiratory status of 
the patient (1). Moreover, it could involve cardiogenic shock 
or syncope (with possible associated falls) and their con-
sequences. These falls could imply other symptoms whose 
significance may depend on the location and the intensity of 
the traumatism. In case of severe brain trauma with epidural 
or subdural hemorrhage, it might be associated with oedema 
and mass effect. Since the overall volume of the cranial vault 
cannot change, an increase in the volume of one of its com-
ponents, or the presence of pathologic ones, necessitates the 
displacement of other structures, an increase in intracranial 
pressure −intracranial hypertension (IH)− or both. One of 
the most hazardous displacements is brain herniation which 
might involve loss of consciousness, pupillary dilation and 
further neurologic deficits, or even coma and death (2).
Case report
A 42-year-old male is admitted in ICU due to a fainting 
episode and consequent fall, which caused him a brain trau-
ma, followed by epileptic seizures, vomits −with probable 
lung aspiration− and coma. 
The medical record reveals that he is obese and that he 
smokes. His family states that the patient presented anx-
iety, oral and upper limbs paresthesias 2 hours before the 
accident. Moreover, he experienced weakness and dyspnea 
decision-making is a compleX issue especially in severe 
multi-pathological patients, Whose processes interact 
With each other and With other treatments, making 
it impossible to folloW regular protocols. in this 
case, the patient suffered from a cranioencephalic 
traumatism and a pulmonary thromboembolism. 
in the case of pulmonary thromboembolism, an 
anticoagulation prophylaXis is recommended While 
in the former it is contraindicated. moreover, 
complications may appear, apparently related or not 
to main diseases. in these situations, it is essential 
to establish priorities and have a vast knoWledge of 
patients' pathologies and the possible complications 
that may emerge. firstly, our aim Was the resolution 
of the brain trauma due to the mortal risk of brain 
herniation. straightaWay We relieved the severe 
subsequent complications of the main processes, 
namely, refractory intracranial hypertension, 
acute respiratory failure and thrombocytopenia. 
once the patient Was stable, pulmonary 
thromboembolism treatment could be set and 
folloWed after clinical improvement and discharge.
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Introduction
Due to the super specialization of medicine, its holistic 
conception from a physiopathological point of view is hard 
to achieve. With this clinical case, we offer an example of 
the decision-making in a multi-pathological patient and the 
complexity it may involve, like for example, those admitted 
in an Intensive Care Unit (ICU). The strategy followed in this 
Department would be to establish a hierarchical list of prob-
lems according to their potential mortal risk, to then provide 
them with a treatment. All of this taking into account the 
possible complications and interactions between treatments 
and concomitant processes. Thus, we combine both support 
and etiological treatments. Thereby, if the patient's physio-
logical reserve allows it and his or her processes evolve fa-
vorably, support measures are reduced until his or her full 
recovery. 
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Coagular o no Coagular. esa es la Cuestión.
To coagulate or not to coagulate. 
That is the question. 
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(MDRA) pulmonary infection so we set him in prone ventila-
tion and change the empiric antibiotic therapy to a directed 
one
The study of the pulmonary thromboembolism (PTE) is 
not conclusive; besides, the ECO-doppler rules out existence 
of deep vein thrombosis, thus implanting an inferior vena 
cava filter is dismissed. Days after, a control TC reveals trian-
gular alveolar opaque areas (Hampton's hump) and bullaes, 
suggesting pulmonary infarction. This deterioration caused 
by prolonged mechanical ventilation entails a percutaneous 
tracheostomy. Just before providing heparin, we notice a 
severe drug-induced thrombocytopenia. It improves after re-
moving all the suspicious drugs and adding corticosteroids. 
After increasing the number of platelets, the PTE is 
treated with fondaparinux and the patient progressively 
gets better and is discharged to the Physical Medicine and 
Rehabilitation Department.
Discussion
This case poses a controversy in medical decisions espe-
cially because of the interaction of each specific treatment 
with these complex concomitant diseases. The torpid pro-
gress and the narrow therapeutic range make this case wor-
thy of discussion.
in the previous 2 days. His Glasgow Coma Score is 4 and he 
has isochoric reactive pupils. Etiological differential diag-
nose of syncope includes neurological, cardiac and vascular 
diseases. Interview, examination and basic complementary 
test (an abnormal simple thoracic radiology and an ordinary 
electrocardiogram) show the necessity of a CT scan test. 
Cranial Computed Tomography (CT) shows a right epidural 
hematoma shifting the mid-line, whereas computed tomog-
raphy pulmonary angiography (CTPA) shows a thrombosis 
of some of the branches of the left and right inferior lobar 
arteries.  
After setting sedoanalgesic, antibiotic, antiepileptic and 
stomach protection treatment, we try to improve respiratory 
function with orotracheal intubation and invasive mechan-
ical ventilation adding a greater oxygen inspiratory fraction 
and positive end-expiratory pressure (PEEP). Furthermore, 
a decompressive craniectomy is performed meanwhile the 
hematoma is evacuated. Nevertheless, the patient suffers 
intraparenchymal hemorrhages, so we carry out a second 
contralateral craniectomy in order to control IH.
Referring to the respiratory condition, a bronchoaspira-
tion pneumonia and bilateral atelectasis produce a severe 
hypoxemia that forces us to optimize the antibiotic and 
respiratory measures. Despite the treatment, the patient 
contracts a multidrug resistant Acinetobacter baumannii 
▲ Figure 2. Head CT scan. Right decompressive hemicraniectomy 
and bilateral acute intraparenchymal hemorrhages.
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and PTE, demonstrate they should receive pharmacologic 
prophylaxis unless contraindicated (6). However, any anti-
coagulation, either with heparin −unfractionated heparin 
(UFH) or low molecular weight heparin (LMWH)− warfarin, 
fibrinolytic agents or thrombin inhibitors may all lead to in-
traparenchymal hemorrhages as a complication (7), hence 
their employment should be avoided not only because of 
the underlying IH, but also because of the tissue damage on 
account of mass effect.
As our priority is to preserve brain integrity, we have 
to avert progression of PTE using alternative measures to 
heparin, such as pneumatic intermittent compression. 
Furthermore, due to the severe refractory hypoxemia of our 
patient, we have to improve his respiratory function using 
different measures as antibiotic prophylaxis, bronchial se-
cretions aspirations, lung protective ventilation strategy 
using small tidal volume with PEEP, alveolar recruitment 
maneuvers, postural changes and prone ventilation. As the 
patient is obese, prone ventilation improves atelectasis in 
dependent zones of the lung and in combination with lung 
recruitment method increases SpO2 (8).
Compounding to patient's severe respiratory and 
neurological condition is the gradual developing of 
Effective management of severe brain trauma involves the 
evacuation of the underlying epidural or subdural haemat-
oma but also the avoidance of IH (3). IH is a severe condi-
tion that can lead to patients' death by herniation. Medical 
treatment of increased intracranial pressure should include 
sedation, permissive hyperventilation, hypothermia, drain-
age of cerebrospinal fluid if necessary, and osmotherapy 
with either mannitol or hypertonic saline (3). Decompressive 
craniectomy might seem an aggressive measure, but it is the 
elective choice when IH becomes resistant to medical treat-
ment. Although complications are extremely rare, this proce-
dure might develop some potentially lethal ones, such as the 
emergence of new brain hemorrhages (4). Secondary brain 
hemorrhages to decompressive craniectomy are thought 
to be caused by rapid brain shift that can produce remote 
bleeding due to the shear stress to the brain vessels (4). 
Regarding the PTE, the diagnostic strategy starts assess-
ing the clinical probability of PTE and is followed by either 
D-dimer testing or CTPA (5). Our patient scored from 9 to 11 
points in Padua Prediction Score for Risk of venous throm-
boembolism, according to which anticoagulation prophy-
laxis is indicated if the risk measured is over 3 points. The 
results in critically ill patients who have a high risk for DVT 
▲ Figure 3. Pulmonary CT scan. Hampton's hump and left atelectasis.
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thrombocytopenia. After discharge different causes as in-
flammatory illness o congenital disorders, the most com-
mon diagnose is drug induced thrombocytopenia (9). This 
could be caused by several drugs that were part of patient's 
treatment as levetiracetam (anticonvulsant), tigecycline 
(antimicrobial used to treat MDRA) and IV metamizol. The 
frequency of drug-induced thrombocytopenia in acutely ill 
patients has been reported to be approximately 19–25% (9). 
Generally, platelet count falls within 7 or more days after 
starting a new drug. When the drug is stopped, the plate-
let count rises rapidly within 1–10 days of withdrawal (9). 
After this episode of thrombocytopenia, TEP treatment with 
fondaparinux is more suitable than heparin due to heparin 
ability to caused immune-mediated thrombocytopenia.
In concurrence with the pulmonary infection, the patient 
has many risk factors that make him susceptible of being 
infected with MDRA, such as mechanical ventilation, stay in 
an ICU for a considerable time period, a severe illness, recent 
surgery and many invasive procedures as well as multiple 
intravenous lines, monitoring devices, surgical drain, and 
indwelling urinary catheters (10). Typically, treatment of A. 
baumannii infection includes aminoglycosides (amikacin) 
in combination with a beta-lactamase-stable beta-lactam 
(piperacillin) often along with beta-lactamase inhibitor 
(tazobactam) or imipenem (10). In case of MDRA, which 
is resistant to at least all penicillins and cephalosporins, 
fluroquinolones and aminoglycosides; carbapenems are the 
treatment of choice (10). Nevertheless, it is suggested that an 
antibiotic therapy should always be guided by in vitro sus-
ceptibility profile of the organism, due to the multiple and 
rapid mechanism of resistance (10). In this case, we set the 
suggested treatment by the 2014 clinical practice guidelines, 
but we directly change empirical treatment with meropen-
em, linezolid and levofloxacin to those that the antibiogram 
indicated as effective (tigecycline and colistin).
The successful outcome supports the effectiveness of the 
medical decisions for future similar situations. It is impor-
tant to consider our established priority, in order to deal with 
all the processes that the patient suffers, and also to have 
an ample knowledge of these so as to be able to foresee the 
possible complications and anticipate to them.
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